Justin Saeks and Bruce Carlson[email protected]InfectiousAntigen tests drive COVID-19 test market to $10.5BEven in the fall of 2020, there are capacity limitations, questions about testing accuracy, and challenges with sample collection. But creative solutions have been emerging at labs to help ease the load during a difficult time.November 9, 2020Page 1 of 1Top StoriesFDA ClearanceKSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapyBiotech firm KSQ Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a phase I and II trial of KSQ-001EX, KSQ’s CRISPR-Cas9 engineered tumor-infiltrating lymphocyte program.Vascular DiseasePotential drug target to prevent small vessel disease identified in studyTrends and FinanceCandel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapiesRheumatoid ArthritisScipher Medicine, Quest Diagnostics collaborate on RA diagnosticsSequencingNanopore sequencing slashes tumor analysis times and costs